A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Background: Mobilising patients early after stroke [early mobilisation (EM)] is thought to contribute to the beneficial effects of stroke unit care but it is poorly defined and lacks direct evidence of benefit. Objectives: We assessed the effectiveness of frequent higher dose very early mobilisation (VEM) after stroke. Design: We conducted a parallel-group, single-blind, prospective randomised controlled trial with blinded end-point assessment using a web-based computer-generated stratified randomisation. Setting: The trial took place in 56 acute stroke units in five countries. Participants: We included adult patients with a first or recurrent stroke who met physiological inclusion criteria. Interventions: Patients received either usual stroke unit care (UC) or UC plus VEM commencing within 24 hours of stroke. Main outcome measures: The primary outcome was good recovery [modified Rankin scale (mRS) score of 0–2] 3 months after stroke. Secondary outcomes at 3 months were the mRS, time to achieve walking 50 m, serious adverse events, quality of life (QoL) and costs at 12 months. Tertiary outcomes included a dose–response analysis. Data sources: Patients, outcome assessors and investigators involved in the trial were blinded to treatment allocation. Results: We recruited 2104 (UK,n = 610; Australasia,n = 1494) patients: 1054 allocated to VEM and 1050 to UC. Intervention protocol targets were achieved. Compared with UC, VEM patients mobilised 4.8 hours [95% confidence interval (CI) 4.1 to 5.7 hours;p < 0.0001] earlier, with an additional three (95% CI 3.0 to 3.5;p < 0.0001) mobilisation sessions per day. Fewer patients in the VEM group (n = 480, 46%) had a favourable outcome than in the UC group (n = 525, 50%) (adjusted odds ratio 0.73, 95% CI 0.59 to 0.90;p = 0.004). Results were consistent between Australasian and UK settings. There were no statistically significant differences in secondary outcomes at 3 months and QoL at 12 months. Dose–response analysis found a consistent pattern of an improved odds of efficacy and safety outcomes in association with increased daily frequency of out-of-bed sessions but a reduced odds with an increased amount of mobilisation (minutes per day). Limitations: UC clinicians started mobilisation earlier each year altering the context of the trial. Other potential confounding factors included staff patient interaction. Conclusions: Patients in the VEM group were mobilised earlier and with a higher dose of therapy than those in the UC group, which was already early. This VEM protocol was associated with reduced odds of favourable outcome at 3 months cautioning against very early high-dose mobilisation. At 12 months, health-related QoL was similar regardless of group. Shorter, more frequent mobilisation early after stroke may be associated with a more favourable outcome. Future work: These results informed a new trial proposal [A Very Early Rehabilitation Trial – DOSE (AVERT–DOSE)] aiming to determine the optimal frequency and dose of EM. Trial registration: The trial is registered with the Australian New Zealand Clinical Trials Registry number ACTRN12606000185561, Current Controlled Trials ISRCTN98129255 and ISRCTN98129255. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 54. See the NIHR Journals Library website for further project information. Funding was also received from the National Health and Medical Research Council Australia, Singapore Health, Chest Heart and Stroke Scotland, Northern Ireland Chest Heart and Stroke, and the Stroke Association. In addition, National Health and Medical Research Council fellowship funding was provided to Julie Bernhardt (1058635), who also received fellowship funding from the Australia Research Council (0991086) and the National Heart Foundation (G04M1571). The Florey Institute of Neuroscience and Mental Health, which hosted the trial, acknowledges the support received from the Victorian Government via the Operational Infrastructure Support Scheme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553 · cited 1×
“Features VEM (n= 1054) UC (n= 1050) Stroke history, n (%) First stroke 878 (83) 843 (80) NIHSS score, mean (IQR) 7 (4–12) 7 (4–12) Mild (1–7) 592 (56) 578 (55) Moderate (8–16) 315 (30) 328 (31) Severe (> 16) 147 (14) 144 (14) Stroke type (Oxfordshire Stroke Classification), n (%) Total anterior circulation infarct 224…”
BackgroundInterobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Classification and natural history of clinically identifiable subtypes of cerebral infarction
Bamford, J., Sandercock, P., Dennis, M., Warlow, C., & Burn, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)93206-o · Cited by 3,294
Emberson, J., Lees, K. R., Lyden, P., Blackwell, L., Albers, G., Bluhmki, E., Brott, T., Cohen, G., Davis, S., Donnan, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60584-5 · Cited by 2,737 · cited 2×
“1Academic Section of Geriatric Medicine, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK 2Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK 3Institute for Ageing and Health, Medical School, Newcastle University, Newcastle upon Tyne, UK 4Rehabilitation Research U…”
Langhorne, P., Bernhardt, J., & Kwakkel, G. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60325-5 · Cited by 2,726
Self-citationPlasticity during stroke recovery: from synapse to behaviour
Murphy, T. H., & Corbett, D. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2735 · Cited by 1,938 · cited 1×
“Hypercholesterolaemia 421 (40) 423 (40) Diabetes mellitus 239 (23) 228 (21) Smoking, n (%) Never smoked 454 (43) 491 (47) Smoker 227 (22) 204 (19) Ex-smoker 352 (33) 341 (33) Unknown 21 (2) 14 (1) Atrial fibrillation 229 (22) 237 (23) Premorbid history, n (%) Premorbid mRS 0 799 (76) 786 (75) 1 145 (14) 158 (15) 2 110…”
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., Loder, E., et al. (2013) · BMJ · doi:10.1136/bmj.f1049 · Cited by 1,776
(2015) · The Lancet · doi:10.1016/s0140-6736(15)60690-0 · Cited by 789
Getting Neurorehabilitation Right: What Can Be Learned From Animal Models?
Krakauer, J. W., Carmichael, S. T., Corbett, D., & Wittenberg, G. F. (2012) · Neurorehabilitation and Neural Repair · doi:10.1177/1545968312440745 · Cited by 591
Bed rest: a potentially harmful treatment needing more careful evaluation
Allen, C., Glasziou, P., & Mar, C. D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10063-6 · Cited by 480
Impact of intensity of practice after stroke: Issues for consideration
Kwakkel, G. (2006) · Disability and Rehabilitation · doi:10.1080/09638280500534861 · Cited by 417
Very Early Constraint-Induced Movement during Stroke Rehabilitation (VECTORS): A single-center RCT
Dromerick, A. W., Lang, C. E., Birkenmeier, R. L., Wagner, J. M., Miller, J. P., Videen, T. O., Powers, W. J., Wolf, S. L., & Edwards, D. F. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ab2b27 · Cited by 399
Treatment in a Combined Acute and Rehabilitation Stroke Unit: Which Aspects Are Most Important?
Indredavik, B., Bakke, F., Slørdahl, S. A., Rokseth, R., & Håheim, L. L. (1999) · Stroke · doi:10.1161/01.str.30.5.917 · Cited by 368 · cited 3×
“Features Patients (N= 2104) Recruitment region, n (%) Australia/New Zealand 1243 (59) Asia 251 (12) UK 610 (29) Patient characteristics Age (years), median (IQR) 73 (63–80) Female, n (%) 818 (40) Risk factors, n (%) Hypertension 1424 (68) Ischaemic heart disease 487 (23) Hypercholesterolaemia 929 (40) Diabetes mellitu…”
BackgroundCumming, T. B., Thrift, A. G., Collier, J. M., Churilov, L., Dewey, H. M., Donnan, G. A., & Bernhardt, J. (2011) · Stroke · doi:10.1161/strokeaha.110.594598 · Cited by 281
Self-citationPrespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)
Bernhardt, J., Churilov, L., Ellery, F., Collier, J., Chamberlain, J., Langhorne, P., Lindley, R. I., Moodie, M., Dewey, H., Thrift, A. G., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002459 · Cited by 221
Self-citationAustin, M. W., Ploughman, M., Glynn, L., & Corbett, D. (2014) · Neuroscience Research · doi:10.1016/j.neures.2014.06.007 · Cited by 153 · cited 1×
“4) < 65, n (%) 331 (31%) 298 (28%) 65–80, n (%) 448 (43%) 481 (46%) > 80, n (%) 275 (26%) 271 (26%) Sex, n (%) Female 411 (39) 407 (39) Male 643 (61) 643 (61) Risk factors, n (%) Hypertension 707 (67) 717 (68) Ischaemic heart disease 235 (22) 251 (24)”
Very early versus delayed mobilisation after stroke
Bernhardt, J., Thuy, M. N., Collier, J. M., & Legg, L. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006187.pub2 · Cited by 134
Self-citationEarly Mobilization After Stroke: Early Adoption but Limited Evidence
Bernhardt, J., English, C., Johnson, L., & Cumming, T. B. (2015) · Stroke · doi:10.1161/strokeaha.114.007434 · Cited by 117 · cited 3×
“Features VEM (n= 1054) UC (n= 1050) Stroke history, n (%) First stroke 878 (83) 843 (80) NIHSS score, mean (IQR) 7 (4–12) 7 (4–12) Mild (1–7) 592 (56) 578 (55) Moderate (8–16) 315 (30) 328 (31) Severe (> 16) 147 (14) 144 (14) Stroke type (Oxfordshire Stroke Classification), n (%) Total anterior circulation infarct 224…”
BackgroundSelf-citationOutcome After Mobilization Within 24 Hours of Acute Stroke: A Randomized Controlled Trial
Sundseth, A., Thommessen, B., & Rønning, O. M. (2012) · Stroke · doi:10.1161/strokeaha.111.646687 · Cited by 113
Olavarría, V. V., Arima, H., Anderson, C. S., Brunser, A. M., Muñoz-Venturelli, P., Heritier, S., & Lavados, P. M. (2014) · Cerebrovascular Diseases · doi:10.1159/000362533 · Cited by 107
Craig, L. E., Bernhardt, J., Langhorne, P., & Wu, O. (2010) · Stroke · doi:10.1161/strokeaha.110.588244 · Cited by 72
Self-citationTay-Teo, K., Moodie, M., Bernhardt, J., Thrift, A. G., Collier, J., Donnan, G., & Dewey, H. (2008) · Cerebrovascular Diseases · doi:10.1159/000155984 · Cited by 67 · cited 3×
“Features Patients (N= 2104) Recruitment region, n (%) Australia/New Zealand 1243 (59) Asia 251 (12) UK 610 (29) Patient characteristics Age (years), median (IQR) 73 (63–80) Female, n (%) 818 (40) Risk factors, n (%) Hypertension 1424 (68) Ischaemic heart disease 487 (23) Hypercholesterolaemia 929 (40) Diabetes mellitu…”
BackgroundSelf-citationEgan, K. J., Janssen, H., Sena, E. S., Longley, L., Speare, S., Howells, D. W., Spratt, N. J., Macleod, M. R., Mead, G. E., & Bernhardt, J. (2014) · Neurorehabilitation and Neural Repair · doi:10.1177/1545968314521694 · Cited by 49 · cited 2×
“Features Patients (N= 2104) Recruitment region, n (%) Australia/New Zealand 1243 (59) Asia 251 (12) UK 610 (29) Patient characteristics Age (years), median (IQR) 73 (63–80) Female, n (%) 818 (40) Risk factors, n (%) Hypertension 1424 (68) Ischaemic heart disease 487 (23) Hypercholesterolaemia 929 (40) Diabetes mellitu…”
BackgroundSelf-citationSkarin, M., Bernhardt, J., Sjöholm, A., Nilsson, M., & Linden, T. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00534.x · Cited by 35 · cited 8×
“Royal Devon and Exeter Hospital (23): C Charnley, M James (MIs), S Bacon, N Booth, A Bowring, L Boxall, J Burt, J Cageao, N Green, K Gupwell, S Keenan, H Kingwell, M Kryszkowska, J Mortimore, B Peace and C Roughan.”
BackgroundInfluentialSelf-citationBernhardt, J., Churilov, L., Dewey, H., Lindley, R. I., Moodie, M., Collier, J., Langhorne, P., Thrift, A. G., Donnan, G., & Collaborators, F. T. A. (2015) · International Journal of Stroke · doi:10.1111/ijs.12423 · Cited by 22
Self-citation
Cited by
Management of Acute Ischemic Stroke
Herpich, F., & Rincon, F. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004597 · Cited by 933
Patients' physical activity in stroke units in Latvia and Sweden
Kārkliņa, A., Chen, E., Bērziņa, G., & Stibrant Sunnerhagen, K. (2021) · Brain and Behavior · doi:10.1002/brb3.2110 · Cited by 12
Yamakawa, S., Nagayama, H., Tomori, K., Ikeda, K., & Niimi, A. (2023) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2022.1045231 · Cited by 10
Metadata
- Authors
- Langhorne, P., Wu, O., Rodgers, H., Ashburn, A., & Bernhardt, J.
- Venue
- Health Technology Assessment
- Published
- 2017-09
- Volume
- 21
- Issue
- 54
- Pages
- 1-120
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2762409437
- Cited by
- 186
- References
- 25
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.